Noah Tong

A recent decision from Anthem Blue Cross Blue Shield in three states to stop paying for anesthesia care in select circumstances has drawn widespread scorn from anesthesiologists and patients.

President-elect Donald Trump and his allies make no secret of their disdain toward federal agencies and their desire to fundamentally disrupt the regulatory state.

President-elect Donald Trump is picking Andrew Ferguson as Federal Trade Commission chair, replacing Lina Khan.

Democratic and Republican lawmakers are calling on insurers to divest their pharmacy benefit manager (PBM) businesses in bills introduced to Congress Dec. 11.

Pharmacy benefit managers were under the microscope from the Federal Trade Commission (FTC), lawmakers and states in 2024.

Pharmacy benefit manager reform is included in a larger-than-anticipated healthcare package, but the PBM lobby is fighting the legislation at the eleventh hour.

The Centers for Medicare & Medicaid Services (CMS) is discontinuing the Medicare Advantage (MA) Value-Based Insurance Design model at the end of 2025.

The 1,500-page continuing resolution to fund the government through Mar. 14 has finally dropped, and it includes a substantial number of healthcare priorities that have trade groups both cheering and jeering.

Tech platform Uno Health is rolling out a self-service guide that shows users financial savings they could be eligible to obtain.

The next administration could transform healthcare—shifting focus from treatment to prevention, slashing federal budgets and peeling back regulations in a bid to fuel innovation.